Live Event At 4pm ET: Why Is The Biden Administration Approving New Oil Trains?
|
Key phrases
Older messages
Will Biden And Buttigieg Turn The Colorado River Into An Oil Slick?
Friday, May 19, 2023
Permit approvals for oil trains came despite derailments. Now, Pete Buttigieg could subsidize the scheme with special tax breaks. Private financiers and fossil fuel producers in Utah have an audacious
🎧 LEVER TIME: Meet The Pundits Who Falsely Blamed Inflation On Workers
Thursday, May 18, 2023
On this week's Lever Time: David speaks with two experts about the growing consensus that corporate profits are driving inflation. 🎧 LEVER TIME: Meet The Pundits Who Falsely Blamed Inflation On
Florida’s Pension Is A Bargaining Chip
Wednesday, May 17, 2023
The governor's 2024 money chase could run up against a federal pay-to-play rule that's previously tripped up other GOP candidates. Yesterday, we reported on Ron DeSantis's major pension
DeSantis Allows Anti-“Woke” Giveaway To Big Wall Street Donors
Tuesday, May 16, 2023
As private equity donated to groups supporting Ron DeSantis, he oversaw a billion-dollar transfer of state employees' retirement dollars into underperforming firms. In today's featured story by
"We Must Build An Alternative"
Monday, May 15, 2023
How Helen Gym's fight to save a hospital turned her into a frontrunner to be Philadelphia's next mayor. In today's featured story below, reporter Matthew Cunningham-Cook profiles
You Might Also Like
Full-crime job
Friday, April 26, 2024
Lawyers for Trump argued before SCOTUS that the president has "total immunity" ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
All of My Friends Have These Sweatpant Jeans
Friday, April 26, 2024
Here's What You Missed on the Strategist The Strategist Every product is independently selected by editors. If you buy something through our links, New York may earn an affiliate commission. All of
🌈 Live a bold & bright life
Friday, April 26, 2024
Introducing our theme for May plus fun stuff to read, watch, and click on curated by CreativeMornings HQ. April 25, 2024 Open in new tab Did a friend forward this? Subscribe today! Speech bubble logo
🕐 Time Is Running Out: Your $99 Offer Expires In 48 Hours
Thursday, April 25, 2024
This advisory has returned a massive 838% since inception compared to the 273% return from the S&P 500 Final 48 Hours Fellow Investor, We recently sent you an exclusive offer to try our flagship
The Professor Protesting Columbia’s Own Students
Thursday, April 25, 2024
Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer THURSDAY, APRIL 25 The Professor Protesting Columbia's Own Students Shai Davidai, a
Before you lose your phone ...
Thursday, April 25, 2024
Do these things now ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Friday Briefing: Supreme Court hears Trump immunity case
Thursday, April 25, 2024
Also, more bodies found in a Gazan mass grave. View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 26, 2024 Author Headshot By Amelia Nierenberg
Microsoft results beat quarterly expectations as profits rise 20% to nearly $22B
Thursday, April 25, 2024
Breaking News from GeekWire GeekWire.com | View in browser BREAKING NEWS Microsoft posted a 17% increase in revenue, to $61.9 billion, with $21.9 billion in profits, up 20%, and earnings of $2.94 per
The Dark Side of Immune
Thursday, April 25, 2024
SCOTUS and Why It's Good to be the King ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Techie-turned-lawmaker uses Microsoft chops as state senator | ‘Acquired’ podcast hosts raising fund
Thursday, April 25, 2024
Amazon to stream Seattle Kraken games | Impinj stock soars | 'Good to Go!' scam warning ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the